ライフサイエンスコーパス: CR

1 CR attenuated aging-related changes in cell type composi

2 CR induces pronounced postprandial peaks in hepatic adro

3 CR moderates intrinsic processes of aging through cellul

4 CR programs in many countries may need to increase their

5 CR rate was 8% in the Kono group versus 18% in the Conve

6 CR up-regulates adropin expression and induces rhythms c

7 CR was achieved in 254 (89%) of 286 patients in the R-CH

8 CR-POPF and Grade C POPF were associated with elevated E

9 CR-POPF developed in 13.6% of patients (N = 753) and med

10 CRs against T. trichiura were 43, 46, and 44% for 8, 16,

11 CRs were seen in 102 of 396 patients (25.8%).

12 in 2016, and assessed CR participation (>=1 CR session attended), timely initiation (participation w

13 l NHL (n = 2), and Burkitt lymphoma (n = 1), CR rates were 74% vs 68% for EPOCH vs EPOCH-vorinostat (

14 seen in 9/14 patients achieving CR+CRh (5/10 CR; 4/4 CRh).

15 Among 366 103 CR-eligible beneficiaries, 89 327 (24.4%) participated i

16 [CR]/partial responses[PRs], 32) versus 13% (CR/PRs, 13); median DOR, 8.1 months (range, 0.03 to >= 1

17 on-free survival (mPFS) of 6 months, and 16% CR vs an ORR of 19%, mPFS of 1.5 months, and 5% CR in cl

18 ), consisting of 1 complete response (CR), 2 CRs in target lesions, 25 partial responses, 18 response

19 he interaction resulting from the EPR:CO(2) -CR co-activation is simply additive for all cardiovascul

20 e EPR and the hypercapnia-induced CR (CO(2) -CR), the haemodynamic responses were not different from

21 the interaction resulting from the EPR:O(2) -CR co-activation is hyper-additive for blood pressure an

22 of the EPR and the hypoxia-induced CR (O(2) -CR), mean arterial pressure and heart rate were signific

23 The day 28 CR/PR rates were similar for sirolimus 64.8% (90% confid

24 he most scenarios (50), patients (N = 3246), CR-POPFs (65.2%), and greatest non-zero discrepancy in C

25 d a response (11 PR [9 CNL and 2 aCML] and 4 CR [CNL]), and 50% had oncogenic CSF3R mutations.

26 Only 1 in 4 CR-eligible Medicare beneficiaries participated in CR an

27 s included 20 complete response (CR; 54%), 5 CR with partial recovery of platelet count (CRp; 14%), a

28 recovery of platelet count (CRp; 14%), and 5 CR with incomplete blood count recovery (14%).

29 vs an ORR of 19%, mPFS of 1.5 months, and 5% CR in classifier-negative patients (P = .0096).

30 % confidence interval [CI], 25.5% to 60.8%); CR 30.3% (95% CI, 15.6% to 48.7%).

31 igh-dose fractionated (HDF) cohort had a 90% CR rate and manageable CRS.

32 ival was observed in patients who achieved a CR versus those who did not (P = .035), with median OS n

33 No patient achieved a CR.

34 Attainment of a CR after CART-19 infusion, regardless of cell dose, is a

35 ients with CR and 1 month in those without a CR (P < .0001).

36 culture-positive sepsis died, and 3 achieved CR.

37 e disease who received VI, 11 (79%) achieved CR (n = 1) or PR (n = 10) after 2 cycles.

38 ved EBV-CTLs from a different donor achieved CR or durable PR (60%) and survived longer than 1 year.

39 atients receiving the highest doses achieved CR and CR with incomplete blood count recovery (CRi) at

40 of patients in the olanzapine group achieved CR in the acute period (78% v 59%; P = .001), delayed pe

41 For patients who achieved CR/PR or stable disease after cycle 1, one year overall

42 However, achieving CR after PCI or CABG surgery might not be feasible owing

43 mated cumulative rates of patients achieving CR or symptom resolution with VDZ vs anti-TNFalpha treat

44 learance was seen in 9/14 patients achieving CR+CRh (5/10 CR; 4/4 CRh).

45 However, in patients achieving CR/CRi after induction therapy, significantly fewer rela

46 Pizza intakes (n = 28) after CR, 2gOBG, 4gOBG, and 4gloMW (mean +/- SEM: 887 +/- 64,

47 (range, stopped before CR to 26 months after CR).

48 gOBG, and 4gloMW were similar to those after CR.

49 The optimal duration of treatment after CR is not yet established.

50 e median number of months of treatment after CR was zero (range, stopped before CR to 26 months after

51 y in commercial and trial settings, although CR rates and DOR were more favorable in patients eligibl

52 recently been used to determine the amyloid-CR interface at atomic resolution.

53 In multivariable analysis, CR was associated with M1b disease and cutaneous versus

54 ptional landscapes associated with aging and CR in a mammal, enhances our understanding of the robust

55 oss various rat tissues undergoing aging and CR.

56 mmune cells were increased during aging, and CR favorably reversed the aging-disturbed immune ecosyst

57 receiving the highest doses achieved CR and CR with incomplete blood count recovery (CRi) at day 28.

58 Median durations of CR+CRh and CR were not reached, with 95% CI lower bounds of 4.6 and

59 ed development of cardiomyopathy in T1D, and CR-Atg5KO-induced adverse phenotypes were rescued by add

60 s who were CR eligible in 2016, and assessed CR participation (>=1 CR session attended), timely initi

61 timal sensing conditions for the paper-based CR biosensor to achieve high sensitivities and specifici

62 sought to evaluate the effects of yoga-based CR (Yoga-CaRe) on major cardiovascular events and self-r

63 ent after CR was zero (range, stopped before CR to 26 months after CR).

64 e factors also mean that comparisons between CR and ICR are subject to multiple confounders and are d

65 es of aging, as well as those ameliorated by CR, remain unclear.

66 hypothalamic metabolic variations caused by CR, respectively.

67 ligand-receptor interplay, were reversed by CR.

68 henyl) with the N-heterocyclic silylenes c-[(CR(2) CH(2) )(NtBu)(2) ]Si: (R=H or methyl) with saturat

69 M=Si-M(CO)(2)(PMe(3))Tp'] with alkynes R(1)C=CR(2) and were comprehensively analyzed by experimental

70 eactions between Au(I) acetylides PPh(3)Au-C=CR, where R = nitrophenyl (PhNO(2)), phenyl (Ph), thioph

71 of benzylic substrates R-H with alkynes H-C=CR' (R' = (hetero)aryl, silyl) that provide C(sp)-C(sp3)

72 at provide C(sp)-C(sp3) coupled products R-C=CR via radical relay with (t)BuOO(t)Bu as oxidant.

73 Calretinin (CR) neurons in lamina II inner convey mechanical allodyn

74 ](-) fragment is isoelectronic to a carbyne (CR).

75 F, 59.8% vs 50.7%, respectively; and for CD: CR, 14.4% vs 32.8%; AP, 62.5% vs 56.0%; and LS, 29.9% vs

76 In budding yeast, Saccharomyces cerevisiae, CR is commonly defined by reduced glucose in the growth

77 field-effect transistor (FET)/chemiresistor (CR) biosensors.

78 se pressor reflex (EPR) and the chemoreflex (CR) are recognized for their sympathoexcitatory effect,

79 se pressor reflex (EPR) and the chemoreflex (CR) on the cardiovascular response to exercise.

80 ed in a Renazzo-type carbonaceous chondrite (CR).

81 The discovery of colorectal (CR) cancer stem cell (CSC) as the cell compartment respo

82 ) in an upfront window; those with complete (CR) or partial response (PR) had VI incorporated into re

83 initiated within 21 days and 26.9% completed CR.

84 - 0.25 kg; P = 0.01) that was matched in CON:CR (-1.24 +/- 0.35 kg; P = 0.01).

85 (n = 8) or control/caloric restriction (CON:CR; n = 8) diet.

86 he intervention was conducted before the CON:CR, in which the diet was provided to match the reductio

87 When compared with CON:CR, eTRF improved whole-body insulin sensitivity [betwee

88 Yoga-CaRe may be an option when conventional CR is unavailable or unacceptable to individuals.

89 Because thermoneutrality counteracts CR-enhanced health span, the multiple metabolites and pa

90 erall response rate (complete remission [CR]/CR with incomplete count recovery) was 72%; it was 97% i

91 e lowest-quartile of median EBL demonstrated CR-POPF rates less than half those in the upper-quartile

92 ate removal and no drain placement for: DSM, CR-POPF, delayed gastric emptying, percutaneous drainage

93 ntrol fuel use and energy expenditure during CR.

94 of core body temperature that occurs during CR.

95 raise its light collection efficiency (i.e., CR energy transfer) by conjugation with multiple CR-abso

96 Colon tumors from either CR-infected ApcP (Min/+) or azoxymethane/dextran sodium

97 ore (FRS) scenarios reflective of endogenous CR-POPF risk.

98 EOT CR rates were 85.3% and 78.3% for those with HPV-positiv

99 Collectively, EPR:CR co-activation results in significant cardiovascular i

100 Since the EPR:CR co-activation with hypoxia potentiates the pressor re

101 pheral haemodynamics, resulting from the EPR:CR interaction in hypoxia, likely having the most crucia

102 Thus, EPR:CR co-activation results in significant interactions bet

103 idity (DSM) and clinically-relevant fistula (CR-POPF) were 19.5% and 17.0%.

104 his review are to summarize the evidence for CR to modify primary and secondary aging; present caveat

105 removal was associated with reduced odds for CR-POPF (OR = 0.35, 95% CI = 0.17-0.73).

106 % of the examined isolates were positive for CR-binding.

107 the populations and regions most at risk for CR service underutilization.

108 y scenarios with increased vulnerability for CR-POPF occurrence.

109 nd 60) displayed increased vulnerability for CR-POPF relative to the moderate-risk zone (both P < 0.0

110 Achieving MRD-free CR of HCL after first-line cladribine is greatly enhance

111 tes were 100% versus 88% (P = .11), MRD-free CR rates 97% versus 24% (P < .0001, primary end point),

112 zard radio favoring CDAR, 0.094) of MRD-free CR.

113 pwise fashion from 500 ms onward, first from CR to IR and then from IR to AR.

114 ganoid assay in colonic crypts isolated from CR-infected mice revealed elevated levels of LRP5/6 and

115 t failure for patients with CR was time from CR to the next melanoma treatment or death.

116 via CR knockout of autophagy-related 5 gene (CR-Atg5KO) led to early onset and accelerated developmen

117 re used for in vitro studies and to generate CR-CSC-based mouse avatars to evaluate tumor growth and

118 o that increases in circulating [S] and gill CR abundance are associated with increases in osmoregula

119 dectin-albendazole arms also revealed higher CRs and egg reduction rates against hookworm than the mo

120 ollaborative developed a road map to improve CR use, including increasing participation rates to >=70

121 Olanzapine significantly improved CR rates for vomiting in children receiving the first cy

122 revealed that axin associates with LRP5/6 in CR-infected crypts, and this association was correlated

123 tilized, there was a significant decrease in CR-POPF (10.7% vs 35.5%, P < 0.001; OR 0.20, 95% confide

124 Although there were differences in CR, symptom resolution, and safety profiles, real-world

125 65.2%), and greatest non-zero discrepancy in CR-POPF rates between scenarios (18-fold).

126 irty-five primary human cultures enriched in CR-CSCs, including four from chemoresistant metastatic l

127 s a statistically significant improvement in CR rate (63% v 42%, P = .016), DOR (median, NR v 5.0 mon

128 rgeon EBL is associated with improvements in CR-POPF.

129 Moreover, in CR-CSC-based mouse avatars, BMP7v exerts an antiangiogen

130 in all patients and were not reached (NR) in CR patients.

131 gible Medicare beneficiaries participated in CR and marked disparities were observed.

132 eneficiaries, 89 327 (24.4%) participated in CR, of whom 24.3% initiated within 21 days and 26.9% com

133 CH detected in AML patients in CR includes true residual or early recurrent AML, myelod

134 Five out of 6 patients in CR were also minimal residual disease negative (MRD-).

135 ctions demonstrate significant reductions in CR-POPF can be obtained with 1-, 2-, and 3-point decreas

136 Substantial reductions in CR-POPF occurrence are projected and obtainable by minim

137 cated on a soft gland demonstrated increased CR-POPF incidence.

138 EBL >400 mL was associated with increased CR-POPF occurrence in 13/20 endogenous risk scenarios.

139 rogressive EBL cohorts displayed incremental CR-POPF rates (8.5%, 13.4%, 15.2%, 16.9%; P < 0.001).

140 ation of the EPR and the hypercapnia-induced CR (CO(2) -CR), the haemodynamic responses were not diff

141 The EPR and hypercapnia-induced CR interaction results in a simple addition of the indiv

142 ctivation of the EPR and the hypoxia-induced CR (O(2) -CR), mean arterial pressure and heart rate wer

143 The EPR and hypoxia-induced CR interaction is hyper-additive for blood pressure and

144 effective than 5 x 10(7) CART-19 at inducing CR without excessive toxicity.

145 ositive paclitaxel (KB-PR) and cisplatin (KB-CR) resistant models.

146 Lastly, we show that the lamprey CR expresses an ancestral, spironolactone-as-agonist str

147 an normalized LC signal intensity values (LC-CR) in magnetization-transfer (MT) images from the Cambr

148 A unidimensional model (within which LC-CR related to a single factor representing all cognitive

149 e a priori two-factor model (within which LC-CR related to separate NA-dependent and NA-independent f

150 ns would be more strongly associated with LC-CR in older versus younger adults.

151 imer agents beyond that of the original lead CR-6.

152 with a CD4+ count <200 cells/mm3 had a lower CR rate.

153 Macrophages from MerTK(CR) mice were resistant to CM-induced efferocytosis defe

154 Old MerTK cleavage-resistant mice (MerTK(CR)) exhibited less neutrophils or polymorpho nuclear ce

155 utrality may represent targets for mimicking CR-associated effects.

156 hs after CDAR versus cladribine monotherapy, CR rates were 100% versus 88% (P = .11), MRD-free CR rat

157 Most CRs were durable but the probability of treatment failur

158 nergy transfer) by conjugation with multiple CR-absorbing (water-soluble) antenna followed by intramo

159 confirmed PR (4%; 90% CI, 1% to 11%), and no CRs were observed.

160 ed by two doses of ipilimumab resulted in no CRs and a low PR/CR conversion.

161 Median durations of CR+CRh and CR were not reached, with 95% CI lower bounds

162 Conversely, the favorable effects of CR on health span are mitigated by elevating ambient tem

163 The structural features of CR binding were unknown for years, mainly because of the

164 Yet, implementation of CR may require unique considerations for the elderly and

165 or more directed and efficient management of CR-POPF.

166 a potential cell-nonautonomous mechanism of CR-induced life span regulation.

167 an urgent need to find alternative models of CR that are inexpensive and may offer choice to subgroup

168 This study showed that (1) a portion of CR could be transferred in the region of the optical spe

169 The day 28 rate of CR/PR with prednisone <=0.25 mg/kg/day was significantly

170 ances our understanding of the robustness of CR as a geroprotective intervention, and uncovers how me

171 Given the reduced sensitivity of CR-CSCs to chemotherapy and the ability of bone morphoge

172 reducing mesenchymal traits and survival of CR-CSCs.

173 median follow-up of 21.1 months from time of CR in patients who did not relapse, the probability of b

174 te response (CR) was calculated from time of CR.

175 tients discontinued treatment at the time of CR.

176 countries in the world, 111 (54.7%) offered CR; data were collected in 93 (83.8% country response ra

177 ant lead 7-methoxy-2,2-dimethylchroman-6-ol (CR-6) with that of the lipophilic cholinesterase inhibit

178 EBL is also felt to be influential on CR-POPF development.

179 ients achieving a complete remission (CR) or CR with incomplete hematologic recovery (CRi) was signif

180 OR, CR and OS rates by day 100 were 86.7, 53.3 and 86.7%, re

181 tioned media collected from stationary-phase CR cultures extended CLS when supplemented into nonrestr

182 Complete remission (CR) plus CR with partial hematologic recovery (CRh) rate was 42.4

183 f ipilimumab resulted in no CRs and a low PR/CR conversion.

184 nivolumab nonresponders who converted to PR/CR after ipilimumab (arm B).

185 ints were the proportion of patients with PR/CR at 1 year after nivolumab discontinuation (arm A) and

186 ; an immunosuppressive TME may also preclude CR.

187 haracteristics and geography, and by primary CR-qualifying event type (acute myocardial infarction ho

188 d through the citrulline-NO pathway promotes CR-triggered hypothermia and that leucine enkephalin dir

189 BMP7v treatment promotes CR-CSC differentiation and recapitulates the cell differ

190 A decrease in PWV(CF) , PWV(CR) , SBP and DBP (-25%, -17%, -4% and -8%, respectively

191 d peripheral (carotid-radial artery PWV, PWV(CR) ) arterial stiffness was measured by pulse-wave velo

192 Cherenkov radiation (CR), the blue light seen in nuclear reactors, is emitted

193 inical management of cervical radiculopathy (CR).

194 inical research use "Completely randomised" (CR), "Randomised block" (RB), or one of the more special

195 In "Completely randomized" (CR) and "Randomised block" (RB) experimental designs, bo

196 e response was 4% and clinical benefit rate (CR + PR + SD > 6 m) was 19%.

197 The primary outcome was cure rate (CR) against T. trichiura, analyzed 13 to 20 days after t

198 nics calculations to examine and rationalize CR binding to amyloids.

199 es between cross-hypersensitivity reactions (CRs), associated with COX-1 inhibition, and selective re

200 study found that human complement receptor (CR) 4 selectively bound fibrillar alphaSN, but not monom

201 a single, ancestral corticosteroid receptor (CR).

202 cephalopod-specific chemotactile receptors (CRs) to detect poorly soluble natural products, thereby

203 Secondary endpoints: clinical recurrence (CR) after 12 and 24 months, ER after 18 months, and surg

204 terized by their capacity to bind Congo red (CR), one of the most used amyloid-specific dyes.

205 technical strategies associated with reduced CR-POPF incidence across various risk strata.

206 The conserved central region (CR) of PrP(C) has been hypothesized to serve as a passiv

207 Despite cardiac rehabilitation (CR) being shown to improve health outcomes among patient

208 Cardiac rehabilitation (CR) is recommended in clinical practice guidelines, but

209 iven the shortage of cardiac rehabilitation (CR) programs in India and poor uptake worldwide, there i

210 memory paradigm assessing correct rejection (CR) of lures, item recognition (IR) and associative reca

211 o first chart-documented clinical remission (CR) and symptom resolution (UC: rectal bleeding [RB], st

212 otherapy has resulted in complete remission (CR) and durable response in highly refractory patients.

213 15 of 16 not reaching a complete remission (CR) before transplantation, 9 of 10 treated with rituxim

214 (AML) include achieving complete remission (CR) by clinicopathological criteria followed by interrog

215 he primary end point was complete remission (CR) on induction.

216 in patients achieving a complete remission (CR) or CR with incomplete hematologic recovery (CRi) was

217 Complete remission (CR) or sustained partial remission (PR) was achieved in

218 Complete remission (CR) plus CR with partial hematologic recovery (CRh) rate

219 these parameters reduced complete remission (CR) rate and ORR with VenG.

220 able toxicity with a 33% complete remission (CR) rate.

221 High complete remission (CR) rates often include minimal residual disease (MRD),

222 e overall response rate (complete remission [CR]/CR with incomplete count recovery) was 72%; it was 9

223 n of patients achieving a complete response (CR) or a very good partial response (VGPR) by independen

224 Efficacy was defined as complete response (CR) rate on end-of-treatment (EOT) imaging or with patho

225 objective was to compare complete response (CR) rates (no vomiting and no rescue medication) between

226 urvival for patients with complete response (CR) was calculated from time of CR.

227 partial response (PR) or complete response (CR) within 6 months discontinued nivolumab and were obse

228 o 74.9%), consisting of 1 complete response (CR), 2 CRs in target lesions, 25 partial responses, 18 r

229 participants who showed a complete response (CR), overall response (OR) and overall survival (OS) by

230 as either partial (PR) or complete response (CR).

231 R) was 29%, including 11% complete response (CR).

232 The primary end point was complete response (CR).

233 the difference in day 28 complete response (CR)/partial response (PR) rates for sirolimus vs prednis

234 est responses included 20 complete response (CR; 54%), 5 CR with partial recovery of platelet count (

235 the two groups: ORR 16% (complete response [CR]/partial responses[PRs], 32) versus 13% (CR/PRs, 13);

236 R) of 78%, including 44% complete responses (CRs).

237 was confirmed by a cardiomyocyte-restricted (CR) Nrf2 transgenic approach in mice.

238 Caloric restriction (CR) improves health span and life span of organisms rang

239 In lean mice, caloric restriction (CR) induces bouts of compulsive binge feeding separated

240 that may be delayed by caloric restriction (CR).

241 Calorie restriction (CR) enhances health span (the length of time that an org

242 nditions of obesity and calorie restriction (CR) is not fully understood yet.

243 Calorie restriction (CR), the reduction of dietary intake below energy requir

244 a results in the depletion of Cajal-Retzius (CR) cells in embryonic stages, thus depriving the develo

245 lar events after complete revascularization (CR) than after incomplete revascularization (ICR) in pat

246 and 2% milk plus hot cereal [Cream of Rice (CR), or instant-oatmeal plus either 3 g oat-bran (2gOBG)

247 ased Lama5 protein in the LN cortical ridge (CR) and around high endothelial venules (HEVs).

248 2 post-infection with Citrobacter rodentium (CR) and tended to decline at days 20-34.

249 A, H and L functioned on both central rows (CR) and lateral rows (LR) of the barley spikes, while B

250 (8.1%) - the only negligible-risk scenario (CR-POPF rate = 0.7%).

251 Globally, supervised CR programs were a median of 24 sessions (n=619, 57.3% p

252 here was significant variation in supervised CR dose by region (P<=0.001), with the Americas (median,

253 characterized the dose offered in supervised CR programs and alternative models worldwide and their p

254 Correlates of supervised CR dose included more involvement of physicians (P=0.026

255 her SEVs concentration at the diagnosis than CR patients (P = 0.034).

256 n the binding mode, our results suggest that CR binding to the HET-s PFD involves a cooperative proce

257 The CR encompasses the regulatory alpha-cleavage locus, and

258 The CR mutant escV or the tankyrase inhibitor XAV939 attenua

259 Our results demonstrate the CR is not a passive linker and the native sequence is cr

260 hough none of them actually named either the CR or RB design.

261 uses neonatal fatality in mice, implying the CR possesses a protective function.

262 nted to specific amino acids enriched in the CR conditioned media (CRCM) as functional molecules, wit

263 F3R-T618I after 6 cycles was greatest in the CR group, compared with the PR and no response groups.

264 antigen-specific CD4+ T cell entry into the CR through HEVs, suppressed T cell activation, and alter

265 P(a) CO(2) ~50 mmHg, pH ~7.26) to modify the CR.

266 To elucidate the role of the CR and determine why CR deletion generates toxicity, we

267 Yet, deletion of the CR causes neonatal fatality in mice, implying the CR pos

268 Additionally, we find that the CR facilitates homodimerization of PrP(C) , attenuating

269 to determine whether scientists had used the CR or RB designs.

270 nditions mimicking unlimited depth using the CR-embarked light source, which is unlike standard PDT,

271 reflexes, with the impact differing when the CR activation is achieved by hypoxia or hypercapnia.

272 Whether S and/or DOC interact with the CR to control osmoregulation in lampreys is still unknow

273 ging and (2) Cherenkov-photodynamic therapy (CR-PDT) on cells could be achieved under conditions mimi

274 study, an online survey was administered to CR programs globally.

275 we compared the global metabolic response to CR of mice housed at 22 degrees C (the standard housing

276 s that modulated the hypothermic response to CR.

277 y contributes significant biological risk to CR-POPF.

278 VDZ vs anti-TNFalpha treatment were for UC: CR, 53.7% vs 31.7%; RB, 66.8% vs 55.8%; and SF, 59.8% vs

279 r obese female subjects who either underwent CR for 3 mo followed by a 4-wk phase of weight maintenan

280 -S anastomosis presented a longer time until CR than patients with side-to-side anastomosis (hazard r

281 etics with micro- or macro-albuminuria UPPod:CR and albuminuria were equally good at predicting eGFR

282 m-albuminuria cohort (n = 75) baseline UPPod:CR was associated with development of albuminuria (P = 0

283 (2)) and norm-albuminuria at baseline, UPPod:CR was associated with eGFR loss rate (P = 0.003).

284 For norm-albuminuric type 2 diabetics UPPod:CR predicted both albuminuria and eGFR loss.

285 pellet podocin mRNA:creatinine ratio: UPPod:CR) and a tubular marker (Urinary pellet aquaporin 2:cre

286 >= 3 ml/min/1.73m(2)/year showed that UPPod:CR and albuminuria each improved the AUC similarly such

287 gnificantly related to eGFR slope were UPPod:CR (P < 0.01) and albuminuria (P < 0.01).

288 Moreover, cardiac autophagy inhibition via CR knockout of autophagy-related 5 gene (CR-Atg5KO) led

289 icare fee-for-service beneficiaries who were CR eligible in 2016, and assessed CR participation (>=1

290 ft in the maximal absorbance wavelength when CR is bound to amyloids.

291 ucidate the role of the CR and determine why CR deletion generates toxicity, we designed PrP(C) const

292 Twenty-one of 25 with CR/CRp had no detectable residual disease (RD; 84%) by f

293 le analysis revealed factors associated with CR-POPF in these scenarios: pancreaticogastrostomy recon

294 Compared with CR, 4gOBG significantly reduced glucose (78 +/- 10 compa

295 ctive cohort dataset of 201 individuals with CR.

296 loping prognostic models in individuals with CR.

297 ee survival was 40.2 months in patients with CR and 1 month in those without a CR (P < .0001).

298 with median OS not reached in patients with CR versus 64 months in those without CR.

299 Time to treatment failure for patients with CR was time from CR to the next melanoma treatment or de

300 ts with CR versus 64 months in those without CR.